Ombretta Turriziani


Titolo Pubblicato in Anno
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose VACCINE 2024
Keeping university open did not increase the risk of SARS-CoV-2 acquisition: A test negative case-control study among students PLOS ONE 2024
Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection CIRCULATION RESEARCH 2023
Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients MICROORGANISMS 2023
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study CLINICAL AND EXPERIMENTAL MEDICINE 2023
Systemic, mucosal immune activation and psycho-sexual health in art-suppressed women living with HIV. Evaluating biomarkers and environmental stimuli VIRUSES 2023
Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients MICROORGANISMS 2023
Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome JOURNAL OF INFECTION 2023
The Many Faces of Immune Activation in HIV-1 Infection. A Multifactorial Interconnection BIOMEDICINES 2023
MicroRNA Expression Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1 Positive Individuals and Relationship with Different Levels of Viral Suppression AIDS RESEARCH AND HUMAN RETROVIRUSES 2023
Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions FRONTIERS IN IMMUNOLOGY 2023
(Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition BIOMEDICINES 2022
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature NEW MICROBIOLOGICA 2022
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis CLINICAL RHEUMATOLOGY 2022
siRNA Transfection Mediated by Chitosan Microparticles for the Treatment of HIV-1 Infection of Human Cell Lines MATERIALS 2022
Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patients JOURNAL OF HEMATOLOGY & ONCOLOGY 2022
Neuro-axonal damage and alteration of blood-brain barrier integrity in COVID-19 patients CELLS 2022
Analysis of viral nucleic acids in duodenal biopsies from adult patients with celiac disease EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 2022
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study INFECTION 2022


  • LS6_5

Interessi di ricerca

L’infezione da SARS-CoV-2: diagnosi molecolare e gestione del paziente
Resistenza alla terapia antiretrovirale: effetti a lungo termine della terapia antiretrovirale sulla cellula e studio dei meccanismi di resistenza cellulare selezionati dopo trattamento. Ruolo dell’espressione di trasportatori di membrana nella resistenza ai farmaci antiretrovirali. Caratterizzazione in vitro di ceppi di HIV farmacoresistenti. Studio delle varianti di HIV-1 farmacoresistenti in soggetti HIV positivi e analisi del possibile ruolo delle varianti di HIV farmacoresistenti archiviate nei serbatoi cellulari, nel fallimento della terapia antivirale.
Significato clinico della viremia residua in HIV: studi volti ad identificare sia i fattori che contribuiscono alla presenza di viremia residua, sia la relazione esistente tra viremia residua e immunoattivazione/infiammazione cronica.
nel soggetto HIV positivo.
Latenza di HIV: Effetti della terapia antiretrovirale sui serbatoi cellulari del virus.
Diagnosi virologica: Studi volti alla validazione e “messa a punto” di test diagnostici. Analisi comparative di test diagnostici commerciali


antiretroviral therapy hiv
HIV latency
drug resistance
antiretroviral therapy hiv

Gruppi di ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma